Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's
Novartis CEO Battles Fallout From Data Manipulation - WSJ
Novartis chief criticises EU move to control pharma licensing in emergencies | Financial Times
Vasant Narasimhan | Novartis
CEO's letter - Novartis Novartis in Society Integrated Report 2022
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis' CEO is “un-bossing” his 125,000 employees
Vas Narasimhan | One Young World
Can Novartis Digitally Transform Clinical Development? - TimmermanReport.com
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Novartis global chief focuses on innovative medicines for Indian market
Novartis CEO's $50 Billion of Deals Was Just the First Act - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AQ6AEJN4IJMKPDF4JS6QOCORLM.jpg "Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters")
Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Indian-origin CEOs take pride in identity': Novartis's Vas Narasimhan
The 'student' of leadership who seeks to inspire his employees | Financial Times
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO On How Yoga & Lessons From His Grandparents Help In Taking Big Professional Decisions - YouTube
Cannabinoids are not a focus area" Novartis CEO
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Novartis appointed Vasant Narasimhan as CEO, effective February 1, 2018
New Novartis chief eyes productivity revolution - SWI swissinfo.ch
